Cargando…
The Signaling Pathway of the ADP Receptor P2Y(12) in the Immune System: Recent Discoveries and New Challenges
P2Y(12) is a G-protein-coupled receptor that is activated upon ADP binding. Considering its well-established role in platelet activation, blocking P2Y(12) has been used as a therapeutic strategy for antiplatelet aggregation in cardiovascular disease patients. However, receptor studies have shown tha...
Autores principales: | Entsie, Philomena, Kang, Ying, Amoafo, Emmanuel Boadi, Schöneberg, Torsten, Liverani, Elisabetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095349/ https://www.ncbi.nlm.nih.gov/pubmed/37047682 http://dx.doi.org/10.3390/ijms24076709 |
Ejemplares similares
-
A role for platelets in metabolic reprogramming of tumor-associated macrophages
por: Kang, Ying, et al.
Publicado: (2023) -
Sex-related differences in the response of anti-platelet drug therapies targeting purinergic signaling pathways in sepsis
por: Amoafo, Emmanuel Boadi, et al.
Publicado: (2022) -
Structural and functional evolution of the P2Y(12)-like receptor group
por: Schöneberg, Torsten, et al.
Publicado: (2007) -
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators
por: Manetti, Dina, et al.
Publicado: (2023) -
Utilization of Pectin from Okra as Binding Agent in Immediate Release Tablets
por: Owusu, Frederick W. A., et al.
Publicado: (2021)